{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:00:06Z","timestamp":1793826006394,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T00:00:00Z","timestamp":1440460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12884-015-0608-y","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T17:19:50Z","timestamp":1440436790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Yan","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fufan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,25]]},"reference":[{"issue":"9499","key":"608_CR1","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/S0140-6736(05)67726-4","volume":"366","author":"JG Ray","year":"2005","unstructured":"Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366(9499):1797\u2013803.","journal-title":"Lancet"},{"issue":"2","key":"608_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00003081-200606000-00009","volume":"49","author":"DJ Barker","year":"2006","unstructured":"Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol. 2006;49(2):270\u201383.","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"608_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1056\/NEJMra0708473","volume":"359","author":"PD Gluckman","year":"2008","unstructured":"Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359(1):61\u201373.","journal-title":"N Engl J Med"},{"issue":"4","key":"608_CR4","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.ajog.2004.06.052","volume":"191","author":"L Dugoff","year":"2004","unstructured":"Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004;191(4):1446\u201351.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"608_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/pd.2234","volume":"29","author":"LC Poon","year":"2009","unstructured":"Poon LC, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH. First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome. Prenat Diagn. 2009;29(6):553\u20139.","journal-title":"Prenat Diagn"},{"issue":"2","key":"608_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/uog.3881","volume":"29","author":"A Pilalis","year":"2007","unstructured":"Pilalis A, Souka AP, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11\u201314 weeks' gestation. Ultrasound Obstet Gynecol. 2007;29(2):135\u201340.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"608_CR7","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/j.1471-0528.2000.tb11618.x","volume":"107","author":"CT Ong LA","year":"2000","unstructured":"LA Ong CT, Spencer K, Munim S, Nicolaides KH. First-trimester maternal serum free beta-human chorionic gonadotropin and pregnancy associated plasma protein-A as predictors of pregnancy complications. Bjog-an International Journal of Obstetrics and Gynaecology. 2000;107:1265\u201370.","journal-title":"Bjog-an International Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"608_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/uog.3876","volume":"29","author":"K Spencer","year":"2007","unstructured":"Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;29(2):128\u201334.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"608_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/pd.2337","volume":"30","author":"PL Hedley","year":"2010","unstructured":"Hedley PL, Placing S, Wojdemann K, Carlsen AL, Shalmi AC, Sundberg K, et al. Free leptin index and PAPP-A: a first trimester maternal serum screening test for pre-eclampsia. Prenat Diagn. 2010;30(2):103\u20139.","journal-title":"Prenat Diagn"},{"issue":"4","key":"608_CR10","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1210\/jcem.87.4.8430","volume":"87","author":"GC Smith","year":"2002","unstructured":"Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 2002;87(4):1762\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2011","key":"608_CR11","first-page":"48","volume":"157","author":"K Jenni","year":"2011","unstructured":"Jenni K, Ranta KR. Jarkko Romppanen, Kari Pulkki, Seppo Heinonen Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption. Eur J Obstet Gynecol Reprod Biol. 2011;157(2011):48\u201352.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"608_CR12","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/j.1471-0528.2010.02690.x","volume":"117","author":"EJ Wortelboer","year":"2010","unstructured":"Wortelboer EJ, Koster MP, Cuckle HS, Stoutenbeek PH, Schielen PC, Visser GH. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG. 2010;117(11):1384\u20139.","journal-title":"BJOG"},{"issue":"4","key":"608_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2010.06.014","volume":"203","author":"F Audibert","year":"2010","unstructured":"Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E, et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol. 2010;203(4):e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"608_CR14","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/uog.6244","volume":"32","author":"R Akolekar","year":"2008","unstructured":"Akolekar R, Zaragoza E, Poon LCY, Pepes S, Nicolaides KH. Maternal serum placental growth factor at 11\u2009+\u20090 to 13\u2009+\u20096\u00a0weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(6):732\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"608_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/pd.2660","volume":"31","author":"R Akolekar","year":"2011","unstructured":"Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11\u201313 weeks. Prenat Diagn. 2011;31(1):66\u201374.","journal-title":"Prenat Diagn"},{"issue":"1","key":"608_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/uog.6280","volume":"33","author":"LCY Poon","year":"2009","unstructured":"Poon LCY, Maiz N, Valencia C, Plasencia W, Nicolaides KH. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol. 2009;33(1):23\u201333.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"608_CR17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/uog.7621","volume":"35","author":"JM Foidart","year":"2010","unstructured":"Foidart JM, Munaut C, Chantraine F, Akolekar R, Nicolaides KH. Maternal plasma soluble endoglin at 11\u201313 weeks' gestation in pre-eclampsia. Ultrasound Obstet Gynecol. 2010;35(6):680\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"608_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.placenta.2013.08.006","volume":"34","author":"E Keikkala","year":"2013","unstructured":"Keikkala E, Vuorela P, Laivuori H, Romppanen J, Heinonen S, Stenman UH. First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia. Placenta. 2013;34(11):1059\u201365.","journal-title":"Placenta"},{"issue":"5","key":"608_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063546","volume":"8","author":"S Kuc","year":"2013","unstructured":"Kuc S, Koster MP, Franx A, Schielen PC, Visser GH. Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia. PLoS One. 2013;8(5), e63546.","journal-title":"PLoS One"},{"issue":"1","key":"608_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000341264","volume":"33","author":"R Akolekar","year":"2013","unstructured":"Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8\u201315.","journal-title":"Fetal Diagn Ther"},{"key":"608_CR21","doi-asserted-by":"publisher","first-page":"263871","DOI":"10.5402\/2012\/263871","volume":"2012","author":"N Moslemi Zadeh","year":"2012","unstructured":"Moslemi Zadeh N, Naghshvar F, Peyvandi S, Gheshlaghi P, Ehetshami S. PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia? ISRN Obstet Gynecol. 2012;2012:263871.","journal-title":"ISRN Obstet Gynecol"},{"issue":"12\u201313","key":"608_CR22","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/pd.2627","volume":"30","author":"KR Goetzinger","year":"2010","unstructured":"Goetzinger KR, Singla A, Gerkowicz S, Dicke JM, Gray DL, Odibo AO. Predicting the risk of pre-eclampsia between 11 and 13\u00a0weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free beta-hCG. Prenat Diagn. 2010;30(12\u201313):1138\u201342.","journal-title":"Prenat Diagn"},{"issue":"3","key":"608_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/uog.8808","volume":"37","author":"I Kirkegaard","year":"2011","unstructured":"Kirkegaard I, Henriksen TB, Uldbjerg N. Early fetal growth, PAPP-A and free beta-hCG in relation to risk of delivering a small-for-gestational age infant. Ultrasound Obstet Gynecol. 2011;37(3):341\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"608_CR24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/pd.2141","volume":"28","author":"K Pihl","year":"2008","unstructured":"Pihl K, Larsen T, Krebs L, Christiansen M. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses. Prenat Diagn. 2008;28(12):1131\u20135.","journal-title":"Prenat Diagn"},{"issue":"4","key":"608_CR25","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.ajog.2004.05.068","volume":"191","author":"D Krantz","year":"2004","unstructured":"Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol. 2004;191(4):1452\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"608_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.0004-8666.2003.00126.x","volume":"43","author":"M Kwik","year":"2003","unstructured":"Kwik M, Morris J. Association between first trimester maternal serum pregnancy associated plasma protein-A and adverse pregnancy outcome. Aust N Z J Obstet Gynaecol. 2003;43(6):438\u201342.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"608_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/uog.5206","volume":"31","author":"TY Leung","year":"2008","unstructured":"Leung TY, Sahota DS, Chan LW, Law LW, Fung TY, Leung TN, et al. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester. Ultrasound Obstet Gynecol. 2008;31(1):10\u20134.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"608_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2009.07.016","volume":"201","author":"KR Goetzinger","year":"2009","unstructured":"Goetzinger KR, Singla A, Gerkowicz S, Dicke JM, Gray DL, Odibo AO. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol. 2009;201(4):e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"608_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000321694","volume":"29","author":"G Karagiannis","year":"2011","unstructured":"Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides KH. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11\u201313 weeks. Fetal Diagn Ther. 2011;29(2):148\u201354.","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"608_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000207554","volume":"25","author":"L Montanari","year":"2009","unstructured":"Montanari L, Alfei A, Albonico G, Moratti R, Arossa A, Beneventi F, et al. The impact of first-trimester serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A on the diagnosis of fetal growth restriction and small for gestational age infant. Fetal Diagn Ther. 2009;25(1):130\u20135.","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"608_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000324318","volume":"30","author":"W Plasencia","year":"2011","unstructured":"Plasencia W, Akolekar R, Dagklis T, Veduta A, Nicolaides KH. Placental volume at 11\u201313 weeks' gestation in the prediction of birth weight percentile. Fetal Diagn Ther. 2011;30(1):23\u20138.","journal-title":"Fetal Diagn Ther"},{"issue":"12","key":"608_CR32","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/pd.2143","volume":"28","author":"LC Poon","year":"2008","unstructured":"Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn. 2008;28(12):1110\u20135.","journal-title":"Prenat Diagn"},{"issue":"3","key":"608_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/pd.1665","volume":"27","author":"NJ Cowans","year":"2007","unstructured":"Cowans NJ, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn. 2007;27(3):264\u201371.","journal-title":"Prenat Diagn"},{"issue":"13","key":"608_CR34","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/pd.2408","volume":"29","author":"K Pihl","year":"2009","unstructured":"Pihl K, Larsen T, Laursen I, Krebs L, Christiansen M. First trimester maternal serum pregnancy-specific beta-1-glycoprotein (SP1) as a marker of adverse pregnancy outcome. Prenat Diagn. 2009;29(13):1256\u201361.","journal-title":"Prenat Diagn"},{"key":"608_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2288-9-48","volume":"9","author":"SJ Lain","year":"2009","unstructured":"Lain SJ, Algert CS, Tasevski V, Morris JM, Roberts CL. Record linkage to obtain birth outcomes for the evaluation of screening biomarkers in pregnancy: a feasibility study. BMC Med Res Methodol. 2009;9:48.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"608_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/pd.2520","volume":"31","author":"LC Poon","year":"2011","unstructured":"Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH. Reference range of birth weight with gestation and first-trimester prediction of small-for-gestation neonates. Prenat Diagn. 2011;31(1):58\u201365.","journal-title":"Prenat Diagn"},{"issue":"2","key":"608_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000303260","volume":"70","author":"B Dane","year":"2010","unstructured":"Dane B, Dane C, Kiray M, Cetin A, Koldas M, Erginbas M. Correlation between first-trimester maternal serum markers, second-trimester uterine artery doppler indices and pregnancy outcome. Gynecol Obstet Invest. 2010;70(2):126\u201331.","journal-title":"Gynecol Obstet Invest"},{"issue":"10","key":"608_CR38","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/pd.3949","volume":"32","author":"KR Goetzinger","year":"2012","unstructured":"Goetzinger KR, Cahill AG, Kemna J, Odibo L, Macones GA, Odibo AO. First-trimester prediction of preterm birth using ADAM12, PAPP-A, uterine artery Doppler, and maternal characteristics. Prenat Diagn. 2012;32(10):1002\u20137.","journal-title":"Prenat Diagn"},{"issue":"1","key":"608_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.placenta.2012.10.013","volume":"34","author":"MJ Stout","year":"2013","unstructured":"Stout MJ, Goetzinger KR, Tuuli MG, Cahill AG, Macones GA, Odibo AO. First trimester serum analytes, maternal characteristics and ultrasound markers to predict pregnancies at risk for preterm birth. Placenta. 2013;34(1):14\u20139.","journal-title":"Placenta"},{"issue":"1","key":"608_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/pd.1898","volume":"28","author":"SL Barrett","year":"2008","unstructured":"Barrett SL, Bower C, Hadlow NC. Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes. Prenat Diagn. 2008;28(1):28\u201335.","journal-title":"Prenat Diagn"},{"issue":"1","key":"608_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/uog.2686","volume":"27","author":"KH Nicolaides","year":"2006","unstructured":"Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol. 2006;27(1):13\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"608_CR42","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2007.11.031","volume":"199","author":"R Romero","year":"2008","unstructured":"Romero R, Kusanovic JP, Than NG, Erez O, Gotsch F, Espinoza J, et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol. 2008;199(2):e1\u2013e11.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"608_CR43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/pd.2287","volume":"29","author":"A Khalil","year":"2009","unstructured":"Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Prenat Diagn. 2009;29(8):781\u20139.","journal-title":"Prenat Diagn"},{"key":"608_CR44","doi-asserted-by":"crossref","unstructured":"Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH. Maternal serum placental protein 13 at 11\u201313 weeks of gestation in preeclampsia. Prenat Diagn. 2009;23.","DOI":"10.1002\/pd.2375"},{"issue":"1","key":"608_CR45","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2007.02.025","volume":"197","author":"I Chafetz","year":"2007","unstructured":"Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2007;197(1):e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"608_CR46","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.placenta.2011.05.006","volume":"32","author":"AO Odibo","year":"2011","unstructured":"Odibo AO, Zhong Y, Goetzinger KR, Odibo L, Bick JL, Bower CR, et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. Placenta. 2011;32(8):598\u2013602.","journal-title":"Placenta"},{"issue":"4","key":"608_CR47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pd.2475","volume":"30","author":"Y Zhong","year":"2010","unstructured":"Zhong Y, Tuuli M, Odibo AO. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn. 2010;30(4):293\u2013308.","journal-title":"Prenat Diagn"},{"issue":"7458","key":"608_CR48","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/bmj.329.7458.168","volume":"329","author":"JJ Deeks","year":"2004","unstructured":"Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329(7458):168\u20139.","journal-title":"BMJ"},{"issue":"4","key":"608_CR49","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","volume":"51","author":"B Huppertz","year":"2008","unstructured":"Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970\u20135.","journal-title":"Hypertension"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-015-0608-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-015-0608-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-015-0608-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T18:23:07Z","timestamp":1718043787000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-015-0608-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,25]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["608"],"URL":"https:\/\/doi.org\/10.1186\/s12884-015-0608-y","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,25]]},"article-number":"191"}}